Rossari Biotech Limited — Important, 25-04-2025: Capacity addition

The Board of Directors of Unitop Chemicals Private Limited and Tristar Intermediates Private Limited have approved significant capacity expansions. Unitop will increase capacity by 18,500 MTPA with an investment of ₹77 Crores, aimed at introducing new product lines and enhancing competitiveness in both domestic and export markets. This addition is planned to be phased in, expected to be completed by Q4 FY 2025-26.

Tristar will also expand its capacity by 3,600 MTPA, requiring an investment of ₹20 Crores, with plans to commission by Q4 FY 2025-26. This upgrade focuses on modernizing equipment to enhance energy efficiency, product consistency, and process safety, leading to lower maintenance costs over time. Both expansions reflect a robust strategy aligned with market demand forecasts, signaling a positive outlook for growth and operational capacity in the coming years. Investors should watch this development closely for potential benefits from enhanced production capabilities.